Outpatient Opioid and Naloxone Prescribing Practices at an Academic Medical Center during the COVID-19 Pandemic

References

• Zelaya CE, Dahlhamer JM, Lucas JW, Connor EM. Chronic Pain and High-Impact Chronic Pain among U.S. Adults, 2019. Hyattsville, MD: National Center for Health Statistics; Nov. 2020. NCHS Data Brief No. 390.
   Google Scholar
• Interagency Pain Research Coordinating Committee. National Pain Strategy Report. Bethesda, MD: National Institutes of Health; 2016. https://www.iprcc.nih.gov/sites/default/files/documents/NationalPainStrategy_508C.pdf. Accessed June 28, 2022.
   Google Scholar
• Mattson CL, Tanz LJ, Quinn K, Kariisa M, Patel P, Davis NL. Trends and geographic patterns in drug and synthetic opioid overdose deaths — United States, 2013–2019. MMWR Morb Mortal Wkly Rep. 2021;70(6):202–7. doi:10.15585/mmwr.mm7006a4.
   PubMed Web of Science ®Google Scholar
• Schieber LZ, Guy GP, Seth P, Losby JL. Variation in adult outpatient opioid prescription dispensing by age and sex — United States, 2008–2018. MMWR Morb Mortal Wkly Rep. 2020;69(11):298–302. doi:10.15585/mmwr.mm6911a5.
   PubMed Web of Science ®Google Scholar
• Dowell D, Haegerich TM, Chou R. CDC guideline for prescribing opioids for chronic pain – United States, 2016. MMWR Recomm Rep. 2016;65(1):1–49. doi:10.15585/mmwr.rr6501e1.
   PubMed Web of Science ®Google Scholar
• Gomes T, Juurlink DN, Antoniou T, Mamdani MM, Paterson JM, van den Brink W. Gabapentin, opioids, and the risk of opioid-related death: a population-based nested case-control study. PLoS Med. 2017;14(10):e1002396. doi:10.1371/journal.pmed.1002396.
   PubMed Web of Science ®Google Scholar
• Gomes T, Greaves S, van den Brink W, Antoniou T, Mamdani MM, Paterson JM, Martins D, Juurlink DN. Pregabalin and the risk for opioid-related death: a nested case-control study. Ann Intern Med. 2018;169(10):732–4. doi:10.7326/M18-1136.
   PubMed Web of Science ®Google Scholar
• Abrahamsson T, Berge J, Ojehagen A, Hakansson A. Benzodiazepine, z-drug and pregabalin prescriptions and mortality among patients in opioid maintenance treatment – a nation-wide register-based open cohort study. Drug Alcohol Depend. 2017;174:58–64. doi:10.1016/j.drugalcdep.2017.01.013.
   PubMed Web of Science ®Google Scholar
• Evoy KE, Sadrameli S, Contreras J, Covvey JR, Peckham AM, Morrison MD. Abuse and misuse of pregabalin and gabapentin: a systematic review update. Drugs. 2021;81(1):125–56. doi:10.1007/s40265-020-01432-7.
   PubMed Web of Science ®Google Scholar
• Watanabe JH, Yang J. Hospitalization and combined use of opioids, benzodiazepines, and muscle relaxants in the United States. Hosp Pharm. 2020;55(5):286–91. doi:10.1177/0018578719894702.
   PubMedGoogle Scholar
• National Conference of State Legislators. Prescribing Policies: States Confront Opioid Overdose Epidemic. Washington, DC: National Conference of State Legislators; June 30, 2019. http://www.ncsl.org/research/health/prescribing-policies-states-confront-opioid-overdose-epidemic.aspx. Accessed April 6, 2021
   Google Scholar
• Kokosky G. Understanding naloxone standing orders is vital. Pharmacy Times, November 20, 2018. https://www.pharmacytimes.com/view/understanding-naloxone-standing-orders-is-vital. Accessed April 6, 2021
   Google Scholar
• Carlton SB. Initial Guidance on House Bill 2174 (HB 2174). Austin, TX: Texas Medical Board; August 30, 2019. https://www.tmb.state.tx.us/dl/B33C8606-F320-3950-CA65-108C5AF1EECC. Accessed January 25, 2021.
   Google Scholar
• Holland KM, Jones C, Vivolo-Kantor AM, Idaikkadar N, Zwald M, Hoots B, Yard E, D'Inverno A, Swedo E, Chen MS, et al. Trends in US emergency department visits for mental health, overdose, and violence outcomes before and during the COVID-19 pandemic. JAMA Psychiatry. 2021;78(4):372–9. doi:10.1001/jamapsychiatry.2020.4402.
   PubMed Web of Science ®Google Scholar
• Behar E, Bagnulo R, Coffin PO. Acceptability and feasibility of naloxone prescribing in primary care settings: a systematic review. Prev Med. 2018;114:79–87. doi:10.1016/j.ypmed.2018.06.005.
   PubMed Web of Science ®Google Scholar
• Texas Department of State Health Services. Opening the State of Texas. Austin, TX: Texas Health and Human Services; June 2021. https://www.dshs.texas.gov/coronavirus/opentexas.aspx. Accessed July 26, 2021.
   Google Scholar
• University Health. What is Carelink? San Antonio, TX: University Health; 2021. https://www.universityhealthsystem.com/patients/support/carelink. Accessed June 14, 2021.
   Google Scholar
• Behar E, Rowe C, Santos GM, Santos N, Coffin PO. Academic detailing pilot for naloxone prescribing among primary care providers in San Francisco. Fam Med. 2017;49(2):122–6.
   PubMed Web of Science ®Google Scholar
• Bounthavong M, Harvey MA, Wells DL, Popish SJ, Himstreet J, Oliva EM, Kay CL, Lau MK, Randeria-Noor PP, Phillips AG, et al. Trends in naloxone prescriptions prescribed after implementation of a national academic detailing service in the Veterans Health Administration: a preliminary analysis. J Am Pharm Assoc (2003). 2017;57(2S):S68–S72. doi:10.1016/j.japh.2016.11.003.
   PubMed Web of Science ®Google Scholar
• Tewell R, Edgerton L, Kyle E. Establishment of a pharmacist-led service for patients at high risk of opioid overdose. Am J Health Syst Pharm. 2018;75(6):376–83. doi:10.2146/ajhp170294.
   PubMed Web of Science ®Google Scholar
• Cariveau D, Fay AE, Baker D, Fagan EB, Wilson CG. Evaluation of a pharmacist-led naloxone coprescribing in primary care. J Am Pharm Assoc. 2019;59(6):867–71. doi:10.1016/j.japh.2019.07.012.
   Google Scholar
• Watson A, Guay K, Ribis D. Assessing the impact of clinical pharmacists on naloxone coprescribing in the primary care setting. Am J Health Syst Pharm. 2020;77(7):568–73. doi:10.1093/ajhp/zxaa007.
   PubMedGoogle Scholar
• Park TW, Saitz R, Ganoczy D, Ilgen MA, Bohnert ASB. Benzodiazepine prescribing patterns and deaths from drug overdose among US veterans receiving opioid analgesics: case-cohort study. BMJ. 2015;350:h2698. doi:10.1136/bmj.h2698.
   PubMed Web of Science ®Google Scholar
• Mikosz CA, Zhang K, Haegerich T, Xu L, Losby JL, Greenspan A, Baldwin G, Dowell D. Indication-specific opioid prescribing for US patients with Medicaid or private insurance, 2017. JAMA Network Open. 2020;3(5):e204514. doi:10.1001/jamanetworkopen.2020.4514.
   PubMedGoogle Scholar
• Swarm R, Abernethy AP, Anghelescu DL, Benedetti C, Blinderman CD, Boston B, Cleeland C, Coyle N, deLeon-Casasola OA, Eilers JG, et al. NCCN adult cancer pain clinical practice guidelines in oncology. J Natl Compr Cancer Network. 2010;8(9):1046–86.
   PubMed Web of Science ®Google Scholar
• Dowell D, Ragan KR, Jones CM, Baldwin GT, Chou R. Draft: CDC Clinical Practice Guideline for Prescribing Opioids – United States, 2022. Atlanta, GA: Centers for Disease Control and Prevention; February 9, 2022. https://www.regulations.gov/document/CDC-2022-0024-0002. Accessed June 28, 2022.
   Google Scholar